Tekla Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-149,835
| Closed | -$1.34M | – | 220 |
|
|
2020
Q2 | $1.34M | Hold |
149,835
| – | – | 0.05% | 183 |
|
|
2020
Q1 | $954K | Hold |
149,835
| – | – | 0.04% | 179 |
|
|
2019
Q4 | $1.25M | Buy |
+149,835
| New | +$1.25M | 0.05% | 176 |
|
|
2019
Q3 | – | Sell |
-120,768
| Closed | -$1.3M | – | 197 |
|
|
2019
Q2 | $1.3M | Sell |
120,768
-120,770
| -50% | -$1.3M | 0.05% | 156 |
|
|
2019
Q1 | $2.3M | Hold |
241,538
| – | – | 0.09% | 125 |
|
|
2018
Q4 | $2.77M | Buy |
241,538
+69,649
| +41% | +$800K | 0.12% | 113 |
|
|
2018
Q3 | $2.91M | Buy |
171,889
+51,377
| +43% | +$871K | 0.11% | 126 |
|
|
2018
Q2 | $1.71M | Buy |
+120,512
| New | +$1.71M | 0.06% | 141 |
|
|
2015
Q3 | – | Sell |
-75,000
| Closed | -$832K | – | 140 |
|
|
2015
Q2 | $832K | Sell |
75,000
-604,100
| -89% | -$6.7M | 0.03% | 100 |
|
|
2015
Q1 | $10.6M | Hold |
679,100
| – | – | 0.42% | 54 |
|
|
2014
Q4 | $10.3M | Sell |
679,100
-71,000
| -9% | -$1.08M | 0.48% | 50 |
|
|
2014
Q3 | $8.09M | Buy |
750,100
+629,700
| +523% | +$6.79M | 0.38% | 55 |
|
|
2014
Q2 | $1.84M | Buy |
120,400
+73,000
| +154% | +$1.12M | 0.17% | 59 |
|
|
2014
Q1 | $857K | Buy |
+47,400
| New | +$857K | 0.09% | 60 |
|